What is Abivax SA ADR (ABVX)?
Abivax SA is a biopharmaceutical company focused on the research and development of therapies for inflammatory diseases, viral infections, and cancer. The company employs a pipeline approach targeting immune system modulation and antiviral mechanisms. Abivax conducts clinical trials to evaluate the safety and efficacy of its drug candidates. It collaborates with academic institutions and industry partners to advance its research programs. The company operates within the regulatory frameworks governing pharmaceutical development and clinical research. Abivax aims to address unmet medical needs by developing innovative treatments based on its proprietary technology platforms.
Abivax SA ADR Stock Price Today: Live Overview
The price today is shaped by ongoing trading for ARLO TECHNOLOGIES ORD, currently at $112.42. Prices have shifted between $110.83 and $116.65 through the session, showing a daily change of -2.4365%.
FAQ: Abivax SA ADR (ABVX)
What is the current price of ABVX stock?
The stock is currently priced at $112.42.
Does ABVX pay dividends?
Abivax SA ADR does not pay dividends.
Does ABVX have a formal corporate presence or regional headquarters in the UAE?
Abivax SA ADR operates in the UAE through partners only, with no official regional office or subsidiary.
What is ABVX best known for?
The company is most famous for its development of innovative therapies in immunology and infectious diseases.
What assets are typically shown together with ABVX?
Commonly shown alongside ABVX: Shimizu Corporation, Brown-Forman, TELUS Corp (CA)
Latest shares articles



